Kevin Sitts

Mr. Sitts leads manufacturing and supply chain operations. Previously, he managed manufacturing operations for Pfizer in McPherson, KS with 380 operations personnel responsible to supply millions of units of drug product per year with multiple manufacturing lines operating 24 hours per day and seven days per week. In addition, Mr. Sitts was Director of Manufacturing for Tolmar Pharmaceuticals, a maker of injectible cancer therapeutics (Eligard) where he managed 80 operating personnel. Previously, he led sterile manufacturing for Meridian Medical Technologies and was with Amylin Pharmaceuticals prior to its purchase by Eli Lilly & Co. Mr. Sitts graduated from Kansas State University.